OMEZ 40 + OMEZ 80
ApprovedCompleted 0 watching 0 views this week๐ฅ Hot
82
Development Stage
โ
Pre-clinicalโ
Phase 1โ
Phase 2โ
Phase 35
ApprovedAbout OMEZ 40 + OMEZ 80
OMEZ 40 + OMEZ 80 is a approved stage product being developed by Dr. Reddy's Laboratories for GERD. The current trial status is completed. This product is registered under clinical trial identifier NCT02922699. Target conditions include GERD.
Hype Score Breakdown
Clinical
30
Activity
20
Company
7
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02922699 | Approved | Completed |
Competing Products
20 competing products in GERD
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Rabeprazole ER + Ranitidine | Eisai | Phase 3 | 77 |
| Rabeprazole sodium | Eisai | Phase 1 | 33 |
| Rabeprazole sodium + Esomeprazole | Eisai | Phase 3 | 77 |
| rabeprazole sodium + Placebo | Eisai | Phase 3 | 77 |
| Rabeprazole ER + Ranitidine | Eisai | Phase 3 | 77 |
| Rabeprazole sodium 5 mg + Rabeprazole sodium 10 mg | Eisai | Phase 1 | 33 |
| rabeprazole + rabeprazole | Eisai | Phase 3 | 77 |
| Rabeprazole sodium + Esomeprazole | Eisai | Phase 3 | 77 |
| Rabeprazole sodium + Esomeprazole | Eisai | Phase 3 | 77 |
| ONO-8539 | Ono Pharmaceutical | Phase 1 | 33 |
| esomeprazole 40 mg | Johnson & Johnson | Pre-clinical | 23 |
| esomeprazole (Nexiumยฎ) + Xolaamยฎ | AstraZeneca | Approved | 85 |
| esomeprazole | AstraZeneca | Pre-clinical | 23 |
| Esomeprazole | AstraZeneca | Approved | 85 |
| Esomeprazole | AstraZeneca | Approved | 85 |
| esomeprazole magnesium | AstraZeneca | Phase 1 | 33 |
| Esomeprazole | AstraZeneca | Approved | 85 |
| Esomeprazole | AstraZeneca | Phase 3 | 77 |
| Esomeprazole (Nexium) | AstraZeneca | Approved | 85 |
| Omeprazole | AstraZeneca | Phase 3 | 77 |